SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-002587
Filing Date
2022-01-10
Accepted
2022-01-10 10:46:37
Documents
12
Period of Report
2022-01-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm222372d2_8k.htm   iXBRL 8-K 25199
  Complete submission text file 0001104659-22-002587.txt   198562

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bdtx-20220110.xsd EX-101.SCH 3081
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdtx-20220110_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdtx-20220110_pre.xml EX-101.PRE 22627
6 EXTRACTED XBRL INSTANCE DOCUMENT tm222372d2_8k_htm.xml XML 3622
Mailing Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39200 | Film No.: 22520221
SIC: 2836 Biological Products, (No Diagnostic Substances)